EXPERT OPIN DRUG SAF 润色咨询

Expert Opinion On Drug Safety

出版年份:2002 年文章数:1611 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:2.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=29927417, cover=https://img.medsci.cn/images/journal/cover/2021/OjO_202109271315017110.jpg, fullname=Expert Opinion On Drug Safety, abbr=EXPERT OPIN DRUG SAF, pyear=2002, frequence=Bimonthly, articleNumbers=1611, citedSelf2015=2.9, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1474-0338, greenSci=https://www.greensci.net/search?kw=1474-0338, scijournal=https://www.scijournal.org/impact-factor-of-EXPERT-OPIN-DRUG-SAF.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.24, medsciHotlight=2.195, medsciHotlight5year=3.11466, citescore=6.1, hIndex=73, impactFactor=3.1, orgnization=Taylor and Francis Ltd., orgnizationUrl=http://www.informapharmascienc, country=United Kingdom, countryCn=英国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://www.tandfonline.com/loi/ieds20#.V48bfkz9cSQ, websiteHits=5427, guideForAuthor=null, guideForAuthorHits=18, submitWebsite=https://mc.manuscriptcentral.com/eods, submitWebsiteHits=1826, content=Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1474-0338.<br /><br />Expert Opinion on Drug Safety (EODS) is a new bimonthly journal providing comprehensive coverage of the safety of new and established drug therapies. With the ever-expanding armamentarium of drugs and drug therapies available, rational pharmacotherapy today is a complex art. At the forefront of this problem is the need to provide the most effective drug regimen whilst avoiding any adverse drug reactions. From the first point of concept to establishment on the market, monitoring the safety of a drug is critical to a drug's development and commercialisation. With pharmaceutical pipelines burgeoning and further growth of medicines likely in the post-genomic era, there is rapid expansion in the quantity of primary data relating to drug safety. Through systematic review and evaluation, Expert Opinion on Drug Safety seeks to unravel this vast amount of information and provide clear and informed guides to this increasingly important area., totalCites=4997, brief=EXPERT OPIN DRUG SAF杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=本刊可能只接收综述类文章或很多文章不被WOS收录, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=EXPERT OPIN DRUG SAF杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=29927417'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.25), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.13), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.1), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.2), GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.016), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.223), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.41), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.649), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.24)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology (medical) , rank=37/237)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY - SCIE , rank=88/270)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1474-0338[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Expert Opinion on Drug Safety[ta], article_number=143, article_number_cn=12, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
EXPERT OPIN DRUG SAF/Expert Opinion On Drug Safety
ISSN
1474-0338
影响指数话题
预警等级
MedSci期刊指数
4.24 (MedSci实时期刊指数) | 3.11466 (5年期刊指数)
CiteScore值
6.1
h-index
73
h5-median
暂无数据
出版社/管理机构
杂志由 Taylor and Francis Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Bimonthly
出版年份
2002
是否OA
部分OA
被收录情况
Science Citation Index Expanded
JCR分区
PHARMACOLOGY & PHARMACY - SCIE 88/270
中科院分区
大类:医学 3区
小类:医学 3 区